BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioMidwest

  Miromatrix Announces Participation in Upcoming Gilmartin Emerging Growth Company Showcase

  Miromatrix Medical Inc. today announced that the company will participate in the Gilmartin Emerging Growth Company Showcase on August 31st, 2022.

  August 23, 2022

   · 

  1 min read
• FDA

  Synlogic Granted FDA Fast Track Designation for SYNB1353 for the Treatment of Homocystinuria (HCU)

  Synlogic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SYNB1353 for the potential treatment of homocystinuria (HCU).

  August 23, 2022

   · 

  6 min read
• Biotech Beach

  NuVasive to Participate in Upcoming Investor Conferences

  NuVasive, Inc. announced today that management will participate in the following investor conferences.

  August 23, 2022

   · 

  2 min read
• Bio NC

  GeneCentric Publishes New Data Comparing Predictive Immune Response Profiles in Patients Treated with Checkpoint Inhibition or IL-2

  GeneCentric Therapeutics announced its new publication in Cancer Research Communications that compares the immunogenomic response profiles to anti-PD-(L)1 or IL-2 therapy and the development of a novel response classifier to IL-2 treatment.

  August 23, 2022

   · 

  3 min read
• Business

  Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Second Quarter 2022

  Promore Pharma AB (publ) publishes its interim report for the second quarter 2022 on 30 August 2022.

  August 23, 2022

   · 

  2 min read
• Drug Development

  VectorY to Present Poster on Huntington’s Preclinical Data at the Hereditary Disease Foundation, August 24-27 in Cambridge, MA

  VectorY announces today that it will present a poster at the Hereditary Disease Foundation 2022 Meeting in Cambridge, Massachusetts, on August 24-27, 2022.

  August 23, 2022

   · 

  3 min read
• Phonak Unveils Lumity, the New Hearing Aid Platform for Fully Immersive Conversations in Virtually any Situation

  Phonak today announces that its next generation of hearing aids will be powered by its latest Lumity platform.

  August 23, 2022

   · 

  6 min read
• Genetown

  Sensei Biotherapeutics to Participate in Upcoming Investor Conferences

  Sensei Biotherapeutics, Inc. today announced that Company management will participate in the following investor conferences in September 2022.

  August 23, 2022

   · 

  1 min read
• BioMidwest

  Geneoscopy Completes Pivotal Colorectal Cancer Trial Enrollment with Diverse Participant Population

  Geneoscopy Inc. today announced completed enrollment of the CRC-PREVENT pivotal trial for its noninvasive, at-home diagnostic screening test to detect colorectal cancer (CRC) and advanced adenomas in average-risk individuals.

  August 23, 2022

   · 

  5 min read
• Genetown

  BeiGene Announces Acceptance of 11th Regulatory Submission for PD-1 Inhibitor Tislelizumab in China

  BeiGene Announces Acceptance of 11th Regulatory Submission for PD-1 Inhibitor Tislelizumab in China.

  August 23, 2022

   · 

  7 min read